This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Some drug products are susceptible to active pharmaceutical ingredient (API) shortages for a variety of reasons and bifurcation in the market for finished dosage form product between brand and generic drugs, for example, likewise can affect the degree of competition and product diversification in a market. Case for Quality. 2016Dec;50:59–70.
PATIENT CASE An elderly, frail nursinghome resident presents to the emergency department (ED) with a three-day history of shortness of breath, altered mental status, and night sweats. In this article we will highlight five things to know about beta-lactam therapeutic drug monitoring by discussing key questions on each point.
The measures are: Endorsement Proportion of Days Covered Composite (PDC-CMP) [Health Plan] Retirement Antipsychotic Use in Persons with Dementia: MDS (APD-MDS) [NursingHome] Initial Opioid Prescribing at High Dosage (IOP-HD) [Health Plan] Initial Opioid Prescribing for Long-Acting or Extended-Release Opioids (IOP-LA) [Health Plan] Use of Opioids at (..)
Endorsement Proportion of Days Covered Composite (PDC-CMP) [Health Plan] Retirement Antipsychotic Use in Persons with Dementia: MDS (APD-MDS) [NursingHome] Initial Opioid Prescribing at High Dosage (IOP-HD) [Health Plan] Initial Opioid Prescribing for Long-Acting or Extended-Release Opioids (IOP-LA) [Health Plan] Use of Opioids at High Dosage and (..)
We organize all of the trending information in your field so you don't have to. Join 5,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content